TheThese FDAoutdated mustrestrictions thoroughlyare reviewmedically alarmingunjustified newbarriers. dataOne showingconservative mifepristonestudy, complicationswhich maywasn't bepeer 22reviewed, timesdoesn't highercancel thanout previouslythe reported.robust Insuranceevidence claimsof fromthe drugs' safety over 865,000the prescriptionspast reveal25 nearlyyears. 11%Rural ofand low-income women experiencesuffer potentiallymost life-threateningfrom complicationsthese withinrestrictions, 45but days.it's Currentobvious safetythis restrictionsis existpart forof goodthe reasonanti-abortion andmovement's protectplot womento fromend aabortion drugaccess thatfor poseseveryone seriousno risksmatter what it takes.
Current safety restrictions exist for good reason. The EPPC report shows a concerning amount of adverse events women have experienced. The FDA must reassess mifepristone's safety and there should be serious consideration to pulling the drug from the market in order to save lives. Kennedy has a chance to right a wrong done by the overzealous, pro-abortion prior presidential administration.
There's a 15% chance that elective abortion will be banned nationally in the United States before Jan. 1, 2030, according to the Metaculus prediction community.
© 2026 Improve the News Foundation.
All rights reserved.
Version 6.18.0